Apple has recently filed a patent application that reveals concepts behind a new Smart Bike system.  The system appears to involve a series of sensors that turn an individual’s iPod into a bicycle computer.  The …

Thailand is making waves on the international patent scene again with its plans to extend compulsory licensing schemes for Sustiva and Kaletra, two important HIV/AIDS drugs.  With Thailand being a familiar face on the USTR’s …

On July 28, 2010, a U.S. appeals court affirmed a lower court decision denying Eli Lilly a patent on a method of using the cancer medicine Gemzar. This rejected patent, which would have expired …

Just weeks after the U.S. Supreme Court supplied the patent community with the vague Bilski decision, the Australian Patent Office has now refined the Australian test for the patentability of business methods.
Prior Australian law …

Latisse, a treatment for eyelash hypotrichosis (another name for having inadequate or not enough eyelashes) sold by the makers of Botox, was originally developed as a glaucoma drug but was remarketed when it was discovered …

Toyota announced last Monday that it has settled a six-year long patent infringement dispute with Paice LLC.  Paice, a Florida-based company, sued Toyota, claiming the third generation Prius and the Lexus HS250h contained technology that …

It looks like the FTC may have made a serious misstep in its investigation into a possible pay-for-delay deal between Watson Pharmaceutical and Cephalon involving Cephalon’s highly successful sleep disorder medication Provigil. A federal judge …

The good: The House of Representatives just passed a proposal giving the Federal Trade Commission more power to fine pharmaceutical companies that strike deals to extend drug patent protection. The bad: Pharmaceutical companies are lobbying …

As news surrounding the major pharmaceutical has become less than cheerful lately in the wake of Merck’s loss over Fosamax and new studies linking Glaxo’s blockbuster diabetes drug Avandia to heart-failure, the industry should enjoy …

USPTO chief David Kappos announced a proposed three-track application system today that allows applicants to select an expedited review process, for an additional fee of course. The goal is to issue a final disposition on …